Exploration of Olfaction and ChiPSO in Pediatric Cystic Fibrosis

被引:0
|
作者
Saak, Tiana M. [1 ]
Tervo, Jeremy P. [1 ]
Moore, Brandon M. [1 ]
Wang, Alicia S. [1 ]
DiMango, Emily [2 ]
Sadeghi, Hossein [3 ]
Gudis, David A. [1 ,4 ]
Overdevest, Jonathan B. [1 ,4 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Div Pulm Allergy & Crit Care Med, New York Presbyterian, Irving Med Ctr, New York, NY 10032 USA
[3] Columbia Univ, Irving Med Ctr, Div Pediat Pulmonol, New York Presbyterian, New York, NY 10032 USA
[4] Columbia Univ, Irving Med Ctr, Dept Otolaryngol Head & Neck Surg, New York Presbyterian, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; children; olfaction; ChiPSO; olfactory importance; quality of life; OLDER-ADULTS; DYSFUNCTION; DEPRESSION; IMPAIRMENT; PREVALENCE; CHILDREN; QUALITY; LIFE;
D O I
10.3390/jcm14082583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Olfactory dysfunction (OD) is a common symptom among people with cystic fibrosis (PwCF) and contributes to environmental safety concerns, nutritional challenges, and an overall diminished quality of life. OD is perceived to progress along the lifespan in PwCF, often due to worsening sinonasal disease. Among children with cystic fibrosis (CwCF), OD is poorly characterized as limited resources and tolerance contribute to challenges in psychophysical olfactory evaluation among pediatric populations. The Children's Personal Significance of Olfaction (ChiPSO) questionnaire was recently proposed as a tool to assess olfaction and the importance of olfactory stimulation among children. This pilot study aimed to evaluate the utility of ChiPSO among a cohort of ethnically diverse CwCF. Methods: Individuals aged 7-17 with physician-diagnosed CF were asked to complete questionnaires, including ChiPSO and the brief questionnaire on olfactory dysfunction (bQOD-NS), prior to undergoing psychophysical olfactory evaluation with the U-Sniff Identification test. Potential associations between questionnaires and olfactory performance, pulmonary function, and demographic characteristics were evaluated using Pearson and Spearman correlations, independent-sample t-tests, Wilcoxon rank sum tests, and multiple linear regression. Results: U-Sniff Identification score positively correlated with the overall ChiPSO total score [r(13) = 0.640, p = 0.010] and its environmental subdomain score [r(13) = 0.774, p < 0.001], though not with the food subdomain [r(13) = 0.450, p = 0.093], the social subdomain [r(13) = 0.343, p = 0.2], or bQOD-NS score [r(11) = -0.125, p = 0.7]. Hispanic ethnicity is associated with ChiPSO (p = 0.041). Conclusions: In this preliminary study, olfactory importance increases with olfactory function among an ethnically diverse sample of CwCF, with a preferential influence of olfactory function on personal importance of environmental olfactory information. While these results should be interpreted with limitations imposed by the pilot nature of our sample size, our pilot data highlights associations with early adolescent development of importance of olfaction that can be disrupted in the setting of progressive disease among CwCF.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] A Qualitative Exploration of Sleep Habits and Intervention Needs Among Youth with Cystic Fibrosis
    Canter, Kimberly S.
    Strang, Abigail
    Franklin, Melanie
    Wilks, Sophie
    Geiser, Dana
    Okonak, Katherine
    Deatrick, Janet A.
    Chidekel, Aaron
    JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2022, 29 (01) : 44 - 53
  • [22] Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis
    Lubovich, Silvina
    Zaragoza, Silvina
    Rodriguez, Viviana
    Buendia, Jefferson
    Camargo Vargas, Bethy
    Alchundia Moreira, Jessica
    Galanternik, Laura
    Ratto, Patricia
    Teper, Alejandro
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (05): : E466 - E471
  • [23] Prevalence of Depression and Antidepressant Therapy Use in a Pediatric Cystic Fibrosis Population
    Ploessl, Cady
    Pettit, Rebecca S.
    Donaldson, Jennifer
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (04) : 488 - 493
  • [24] Management of Mental Health in Cystic Fibrosis
    Bathgate, Christina Jayne
    Hjelm, Michelle
    Filigno, Stephanie S.
    Smith, Beth A.
    Georgiopoulos, Anna M.
    CLINICS IN CHEST MEDICINE, 2022, 43 (04) : 791 - 810
  • [25] Pediatric hospital in the home: clinical outcomes for treatment of a cystic fibrosis respiratory exacerbation
    Hough, Judith
    Christensen, Hannah
    PHYSIOTHERAPY THEORY AND PRACTICE, 2021, 37 (12) : 1298 - 1305
  • [26] The dance of cystic fibrosis: Experiences of living with cystic fibrosis as an adult
    Varilek, Brandon M.
    Isaacson, Mary J.
    JOURNAL OF CLINICAL NURSING, 2020, 29 (17-18) : 3553 - 3564
  • [27] Improving nutritional status in a pediatric cystic fibrosis center
    Ramirez, Ixsy
    Filbrun, Amy
    Hasan, Aws
    Kidwell, Kelley M.
    Nasr, Samya Z.
    PEDIATRIC PULMONOLOGY, 2015, 50 (06) : 544 - 551
  • [28] The impact of cystic fibrosis on the immunologic profile of pediatric patients
    Bernardi, Daniela M.
    Ribeiro, Antonio F.
    Mazzola, Tais N.
    Vilela, Maria M. S.
    Sgarbieri, Valdemiro C.
    JORNAL DE PEDIATRIA, 2013, 89 (01) : 40 - 47
  • [29] Biomarkers in Pediatric Lung Diseases Including Cystic Fibrosis
    Parisi, Giuseppe Fabio
    Papale, Maria
    Tardino, Lucia
    Nenna, Raffaella
    Midulla, Fabio
    Leonardi, Salvatore
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (03) : 163 - 173
  • [30] Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis
    Caceres Guido, Paulo
    Perez, Mariel
    Halac, Alicia
    Ferrari, Mariela
    Ibarra, Manuel
    Licciardone, Nieves
    Castanos, Claudio
    Gravina, Luis P.
    Jimenez, Cristina
    Garcia Bournissen, Facundo
    Schaiquevich, Paula
    PEDIATRIC PULMONOLOGY, 2019, 54 (11) : 1801 - 1810